NuCana Plc (NCNA)

2.16 +0.20 (+10.20%) USD  |  NASDAQ  |  Mar 06, 16:00
2.45 +0.29 (+13.43%) Pre-Market: 20:00
More

NuCana Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for NCNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
Autolus Therapeutics Plc Upgrade
Mereo BioPharma Group Plc --
Bicycle Therapeutics Plc Upgrade
DBV Technologies SA --